Hyris developed a rapid T-cell test to track patients' immunity levels to SARS-CoV-2 for global clinical use after having inked an exclusive licensing agreement with Duke-NUS Medical School. This new solution leverages the Hyris SystemTM, a proprietary platform that enables genetic testing in any setting, at any time, with results available in real-time through its AI-powered platform.
Read Press ReleaseHopeHealth will leverage TruMed's products to protect its vaccines, medications, and supplies and further enhance patient safety.
Read Press ReleaseNew collaboration empowers a leading home care and hospice EMR software provider to help its clients more effectively onboard and develop staff, drive quality initiatives, and reduce unnecessary onsite visits.
Read Press Release